Core Insights - Cannabix Technologies Inc. has achieved a significant milestone by receiving a Validation Packet from Omega Laboratories for its Marijuana Breath Test (MBT) technology, which tests for delta-9 THC in breath samples [1][2] - The validation process confirms the capability to simultaneously quantify Δ-9-THC, Δ-8-THC, CBD, and CBN in breath aerosols, establishing Cannabix and Omega as leaders in breath testing for recent marijuana use [2][3] - The strategic partnership between Cannabix and Omega includes plans for commercialization, marketing, and distribution of the MBT, with Omega integrating Cannabix's Breath Cartridges into its services [3][4] Company Overview - Cannabix Technologies Inc. specializes in developing breath testing technologies for marijuana and alcohol, focusing on detecting recent use of delta-9 THC [7] - Omega Laboratories, based in Ohio, has over 24 years of experience in drug testing and offers advanced testing solutions to over 6,000 clients globally [5][6] - The partnership allows Omega to appoint a board member from its side, reflecting a collaborative approach to advancing the MBT technology [4]